Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension

Journal of Urology

Volumn 171, Issue 3, 2004, Pages 1093-1097

  Naya, Yoshio ^a   Slaton, Joel W ^a,b   Troncoso, Patricia ^a   Okihara, Koji ^a,c   Babaian, R Joseph ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Neoplasm staging; Patient selection; Prostate; Prostatectomy

Indexed keywords

ADULT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 1542297834     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000103929.91486.29     Document Type: Article

References (23)

1. Murphy, G. P., Natarajan, N., Pontes, J. E., Schmitz, R. L., Smart, C. R., Schmidt, J. D. et al: The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol, 127: 928, 1982
2. Mettlin, C., Lee, F., Drago, J., Murphy, G. P and Investigators of the American Cancer Society National Prostate Cancer Detection Project: The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer, 67: 2949, 1991
3. Mettlin, C., Murphy, G. P., Lee, F., Littrup, P. J., Chesley, A., Babaian, R. et al: Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. Cancer, 72: 1701, 1993
4. Graefen, M., Haese, A., Pichlmeier, U., Hammerer, P. G., Noldus, J., Butz, K. et al: A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol, 165: 857, 2001
5. Jakse, G., Brehmer, B., Borchers, H., Verger-Kuhnke, A. and Biesterfeld, S.: Potency-sparing radical perineal prostatectomy. Urologe A, 42: 382, 2003
6. Walsh, P. C.: Radical prostatectomy, preservation of sexual function, cancer control. The controversy. Urol Clin North Am, 14: 663, 1987
7. Catalona, W. J.: Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy. Urol Clin North Am, 17: 819, 1990
8. Bigg, S. W., Kavoussi, L. R. and Catalona, W. J.: Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer. J Urol, 144: 1420, 1990
9. Huland, H., Hubner D. and Henke, R. P.: Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, N0 prostatic carcinoma. Urology, 44: 211, 1994
10. Sanwick, J. M., Dalkin, B. L. and Nagle, R. B.: Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery. Urology, 52: 814, 1998
11. Graefen, M., Hammerer, P., Michl, U., Noldus, J., Haese, A., Henke, R. P. et al: Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology, 51: 437, 1998
12. Smith, R. C., Partin, A. W., Epstein, J. I. and Brendler, C. B.: Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J Urol, 156: 454, 1996
13. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Fondurulia, J. and Chen, M. H.: Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer J Clin Oncol, 18: 1164, 2000
14. Babaian, R. J., Troncoso, P., Bhadkamkar, V. A. and Johnston, D. A.: Analysis of clinopathologic factors predicting outcome after radical prostatectomy. Cancer, 91: 1414, 2001
15. Taneja, S. S., Penson, D. F., Epelbaum, A., Handler, T., Lepor, H. and Jarrard, D. F.: Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen? J Urol, 162: 1352, 1999
16. Willis, M. L., Sauvageot, J., Partin, A. W., Gurganus, R. and Epstein, J. I.: Ability of sextant biopsies to predict radical prostatectomy stage. Urology, 51: 759, 1998
17. Rogatsch, H., Moser, P., Volgger, H., Horninger, W., Bartsch, G., Mikuz, G. et al: Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens. Hum Pathol, 31: 1102, 2000
18. Egawa, S., Suyama, K., Matsumoto, K., Satoh, T., Uchida, T., Kuwao, S. et al: Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology, 52: 433, 1998
19. Bismar, T. A., Lewis, J. S., Jr., Vollmer, R. T. and Humphrey, P. A.: Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol, 27: 432, 2003
20. Sebo, T. J., Bock, B. J., Cheville, J. C., Lohse, C., Wollan, P. and Zincke, H.: The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol, 163: 174, 2000
21. Goto, Y., Ohori, M. and Scardino, P. T.: Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol, 5: 337, 1998
22. Terris, M. K. and McNeal, J. E.: Application of tissue-marking ink to prostate biopsy specimens. Prostate, 50: 247, 2002
23. Cheng, L., Darson, M. F., Bergstralh, E. J., Slezak, J., Myers, R. P. and Bostwick, D. G.: Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer, 86: 1775, 1999